Retraction Note: Novel mannich-based derivative of 2-mercaptobenzimidazole (AK7): a new candidate for the treatment of inflammatory arthritis owing to its NF-κB1 inhibitory potential
Naunyn Schmiedebergs Arch Pharmacol
.
2024 Aug;397(8):6273.
doi: 10.1007/s00210-024-03267-5.
Authors
Gagun Kamran
1
,
Hafiz Amir Ali Kharl
2
,
Muhammad Nasir Hayat Malik
3
,
Waqas Younis
1
,
Humaira Nadeem
2
,
Aymun Madni Zubair
1
,
Muhammad Atif Hayat Malik
4
,
Shah Jahan
5
,
Ishtiaq Ahmed
6
,
Ramla Shabbir
1
,
Asma Akram
7
,
Irfan Anjum
1
,
Muhammad Atif
1
,
Moosa Raza
1
,
Gull E Zahra Kamla
8
Affiliations
1
Department of Pharmacology, Faculty of Pharmacy, The University of Lahore, Lahore, Pakistan.
2
Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan.
3
Department of Pharmacology, Faculty of Pharmacy, The University of Lahore, Lahore, Pakistan.
[email protected]
.
4
Orthopaedics Unit, King Edward Medical University, Lahore, Mayo Hospital, Lahore, Pakistan.
5
Department of Immunology, University of Health Sciences, Lahore, Pakistan.
6
Department of Pathobiology, University of Veterinary and Animal Sciences (Jhang Campus), Lahore, Pakistan.
7
Department of Orthopedics, Govt Khawaja Muhammad Safdar Medical College, Sialkot, Pakistan.
8
FMH College of Medicine and Dentistry, Lahore, Pakistan.
PMID:
38967828
DOI:
10.1007/s00210-024-03267-5
No abstract available
Publication types
Retraction Notice